Although TGF-β is both a tumour suppressor and tumour promoter, TGF-β inhibitors are currently widely tested for the treatment of cancer (Muraoka-Cook et al, 2004; Elliott and Blobe, 2005; Lahn et al, 2005). The gene discussed is TGFB1; the disease is neoplasm.